Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$702,468	$701,780	$659,191	$616,981
Gross Profit	269,558	249,947	238,060	189,827
EBITDA	146,763	151,961	45,709	138,325
EBIT	87,802	96,389	-9,819	81,392
Net Income	11,757	5,994	-91,643	-98,649
Net Change In Cash	702,468	701,780	659,191	616,981
Free Cash Flow	121,062	28,203	-24,170	104,131
Cash	74,006	43,769	46,520	91,542
Basic Shares	309,647	318,957	307,279	243,711

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$2,393,607	$2,212,304	$2,093,669	$1,992,523
Gross Profit	820,565	784,708	768,973	628,393
EBITDA	500,782	150,425	450,004	381,047
EBIT	271,382	-89,750	216,598	145,660
Net Income	-83,993	-254,789	20,170	68,578
Net Change In Cash	2,393,607	2,212,304	2,093,669	1,992,523
Cost of Revenue		-215,829	-90,484	193,262
Free Cash Flow	276,388	-25,495	189,181	312,815
Cash	91,542	25,976	247,790	341,378
Basic Shares	176,136	150,944	151,821	148,913